![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Non-adherence is the most important risk factor for
ledipasvir/sofosbuvir HCV treatment failure in the real world
|
|
|
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Dost Sarpel, Isaac Wasserman, Alyssa Trochtenberg, Kian Bichoupan, David DelBello, Ponni V Perumalswami, Alyson Harty, Daniel Fierer, Michael Mullen, Douglas Dieterich, Andrea D. Branch
Icahn School of Medicine at Mount Sinai, New York, NY, United States
![HIV1](../images/112116/112116-14/HIV1.gif)
![HIV2](../images/112116/112116-14/HIV2.gif)
![HIV3](../images/112116/112116-14/HIV3.gif)
![HIV4](../images/112116/112116-14/HIV4.gif)
![HIV5](../images/112116/112116-14/HIV5.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|